Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice

Shih Ping Liu, Ying Shiuan Li, Cheng Ming Lee, Chia Hung Yen, Yi Jen Liao, Shiu Feng Huang, Chau Heng Chien, Yi Ming Arthur Chen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In both humans and rodents, males are known to be more susceptible than females to hepatocarcinogenesis. We have previously reported that glycine N-methyltransferase (GNMT) interacts with aflatoxin B1 (AFB 1) and reduces both AFB1-DNA adduct formation and hepatocellular carcinoma (HCC) in mice. We also reported that 50% of the males and 100% of the females in a small group of Gnmt null (Gnmt-/-) mice developed HCC, with first dysplastic hepatocellular nodules detected at mean ages of 17 and 16.5 months, respectively. In our study, we tested our hypothesis that male and female Gnmt-/- mice are susceptible to AFB1 carcinogenesis, and that the absence of Gnmt expression may accelerate AFB1-induced liver tumorigenesis. We inoculated Gnmt-/- and wild-type mice intraperitoneally with AFB1 at 7 days and 9 weeks of age and periodically examined them using ultrasound. Dysplastic hepatocellular nodules were detected in six of eight males and five of five females at 12.7 and 12 months of ages, respectively. Dysplastic hepatocellular nodules from 5/8 (62.5%) male and 4/5 (80%) female Gnmt-/- mice were diagnosed as having HCC, ∼6 months earlier than AFB1-treated wild-type mice. Results from microarray and real-time PCR analyses indicate that five detoxification pathway-related genes were downregulated in AFB1-treated Gnmt-/- mice: Cyp1a2, Cyp3a44, Cyp2d22, Gsta4 and Abca8a. In summary, we observed overall higher susceptibility to AFB1-related HCC in Gnmt-/- mice, further evidence that GNMT overexpression is an important contributing factor to liver cancer resistance.

Original languageEnglish
Pages (from-to)511-523
Number of pages13
JournalInternational Journal of Cancer
Volume128
Issue number3
DOIs
Publication statusPublished - Feb 1 2011
Externally publishedYes

Fingerprint

Glycine N-Methyltransferase
Aflatoxin B1
Knockout Mice
Hepatocellular Carcinoma
Carcinogenesis
DNA Adducts
Liver Neoplasms
Real-Time Polymerase Chain Reaction
Rodentia
Down-Regulation

Keywords

  • aflatoxin B
  • detoxification
  • gender disparity
  • gene knockout mice
  • GNMT
  • hepatocarcinogenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice. / Liu, Shih Ping; Li, Ying Shiuan; Lee, Cheng Ming; Yen, Chia Hung; Liao, Yi Jen; Huang, Shiu Feng; Chien, Chau Heng; Chen, Yi Ming Arthur.

In: International Journal of Cancer, Vol. 128, No. 3, 01.02.2011, p. 511-523.

Research output: Contribution to journalArticle

Liu, Shih Ping ; Li, Ying Shiuan ; Lee, Cheng Ming ; Yen, Chia Hung ; Liao, Yi Jen ; Huang, Shiu Feng ; Chien, Chau Heng ; Chen, Yi Ming Arthur. / Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice. In: International Journal of Cancer. 2011 ; Vol. 128, No. 3. pp. 511-523.
@article{4e74182b7ea3425db52ead7e3d69adc6,
title = "Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice",
abstract = "In both humans and rodents, males are known to be more susceptible than females to hepatocarcinogenesis. We have previously reported that glycine N-methyltransferase (GNMT) interacts with aflatoxin B1 (AFB 1) and reduces both AFB1-DNA adduct formation and hepatocellular carcinoma (HCC) in mice. We also reported that 50{\%} of the males and 100{\%} of the females in a small group of Gnmt null (Gnmt-/-) mice developed HCC, with first dysplastic hepatocellular nodules detected at mean ages of 17 and 16.5 months, respectively. In our study, we tested our hypothesis that male and female Gnmt-/- mice are susceptible to AFB1 carcinogenesis, and that the absence of Gnmt expression may accelerate AFB1-induced liver tumorigenesis. We inoculated Gnmt-/- and wild-type mice intraperitoneally with AFB1 at 7 days and 9 weeks of age and periodically examined them using ultrasound. Dysplastic hepatocellular nodules were detected in six of eight males and five of five females at 12.7 and 12 months of ages, respectively. Dysplastic hepatocellular nodules from 5/8 (62.5{\%}) male and 4/5 (80{\%}) female Gnmt-/- mice were diagnosed as having HCC, ∼6 months earlier than AFB1-treated wild-type mice. Results from microarray and real-time PCR analyses indicate that five detoxification pathway-related genes were downregulated in AFB1-treated Gnmt-/- mice: Cyp1a2, Cyp3a44, Cyp2d22, Gsta4 and Abca8a. In summary, we observed overall higher susceptibility to AFB1-related HCC in Gnmt-/- mice, further evidence that GNMT overexpression is an important contributing factor to liver cancer resistance.",
keywords = "aflatoxin B, detoxification, gender disparity, gene knockout mice, GNMT, hepatocarcinogenesis",
author = "Liu, {Shih Ping} and Li, {Ying Shiuan} and Lee, {Cheng Ming} and Yen, {Chia Hung} and Liao, {Yi Jen} and Huang, {Shiu Feng} and Chien, {Chau Heng} and Chen, {Yi Ming Arthur}",
year = "2011",
month = "2",
day = "1",
doi = "10.1002/ijc.25386",
language = "English",
volume = "128",
pages = "511--523",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice

AU - Liu, Shih Ping

AU - Li, Ying Shiuan

AU - Lee, Cheng Ming

AU - Yen, Chia Hung

AU - Liao, Yi Jen

AU - Huang, Shiu Feng

AU - Chien, Chau Heng

AU - Chen, Yi Ming Arthur

PY - 2011/2/1

Y1 - 2011/2/1

N2 - In both humans and rodents, males are known to be more susceptible than females to hepatocarcinogenesis. We have previously reported that glycine N-methyltransferase (GNMT) interacts with aflatoxin B1 (AFB 1) and reduces both AFB1-DNA adduct formation and hepatocellular carcinoma (HCC) in mice. We also reported that 50% of the males and 100% of the females in a small group of Gnmt null (Gnmt-/-) mice developed HCC, with first dysplastic hepatocellular nodules detected at mean ages of 17 and 16.5 months, respectively. In our study, we tested our hypothesis that male and female Gnmt-/- mice are susceptible to AFB1 carcinogenesis, and that the absence of Gnmt expression may accelerate AFB1-induced liver tumorigenesis. We inoculated Gnmt-/- and wild-type mice intraperitoneally with AFB1 at 7 days and 9 weeks of age and periodically examined them using ultrasound. Dysplastic hepatocellular nodules were detected in six of eight males and five of five females at 12.7 and 12 months of ages, respectively. Dysplastic hepatocellular nodules from 5/8 (62.5%) male and 4/5 (80%) female Gnmt-/- mice were diagnosed as having HCC, ∼6 months earlier than AFB1-treated wild-type mice. Results from microarray and real-time PCR analyses indicate that five detoxification pathway-related genes were downregulated in AFB1-treated Gnmt-/- mice: Cyp1a2, Cyp3a44, Cyp2d22, Gsta4 and Abca8a. In summary, we observed overall higher susceptibility to AFB1-related HCC in Gnmt-/- mice, further evidence that GNMT overexpression is an important contributing factor to liver cancer resistance.

AB - In both humans and rodents, males are known to be more susceptible than females to hepatocarcinogenesis. We have previously reported that glycine N-methyltransferase (GNMT) interacts with aflatoxin B1 (AFB 1) and reduces both AFB1-DNA adduct formation and hepatocellular carcinoma (HCC) in mice. We also reported that 50% of the males and 100% of the females in a small group of Gnmt null (Gnmt-/-) mice developed HCC, with first dysplastic hepatocellular nodules detected at mean ages of 17 and 16.5 months, respectively. In our study, we tested our hypothesis that male and female Gnmt-/- mice are susceptible to AFB1 carcinogenesis, and that the absence of Gnmt expression may accelerate AFB1-induced liver tumorigenesis. We inoculated Gnmt-/- and wild-type mice intraperitoneally with AFB1 at 7 days and 9 weeks of age and periodically examined them using ultrasound. Dysplastic hepatocellular nodules were detected in six of eight males and five of five females at 12.7 and 12 months of ages, respectively. Dysplastic hepatocellular nodules from 5/8 (62.5%) male and 4/5 (80%) female Gnmt-/- mice were diagnosed as having HCC, ∼6 months earlier than AFB1-treated wild-type mice. Results from microarray and real-time PCR analyses indicate that five detoxification pathway-related genes were downregulated in AFB1-treated Gnmt-/- mice: Cyp1a2, Cyp3a44, Cyp2d22, Gsta4 and Abca8a. In summary, we observed overall higher susceptibility to AFB1-related HCC in Gnmt-/- mice, further evidence that GNMT overexpression is an important contributing factor to liver cancer resistance.

KW - aflatoxin B

KW - detoxification

KW - gender disparity

KW - gene knockout mice

KW - GNMT

KW - hepatocarcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=78649831564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649831564&partnerID=8YFLogxK

U2 - 10.1002/ijc.25386

DO - 10.1002/ijc.25386

M3 - Article

C2 - 20473876

AN - SCOPUS:78649831564

VL - 128

SP - 511

EP - 523

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -